Detalhe da pesquisa
1.
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.
Nature
; 593(7859): 429-434, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012082
2.
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.
Nat Commun
; 14(1): 2776, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188660
3.
Lipid nanoparticles silence tumor necrosis factor α to improve wound healing in diabetic mice.
Bioeng Transl Med
; 4(1): 75-82, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680320
4.
Recent advances in biomaterials for the treatment of diabetic foot ulcers.
Biomater Sci
; 5(10): 1962-1975, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28829074
5.
Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
Acta Biomater
; 32: 120-128, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689461